Gastrointestinal Cancer Clinical Trials

Gastrointestinal Cancer Clinical Trials

Clinical Trial: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Clinical Trial: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo) Sponsor and CollaboratorsAIO-Studien-gGmbH, Fresenius Biotech GmbH Principal InvestigatorFlorian Lordick, Prof. Dr., Medizinische Klinik III, Städtisches Klinikum Braunschweig gGmbH ClinicalTrials.gov Identifier NCT01504256Continue Reading

Next post in Gastrointestinal Cancer Clinical Trials